Natural variation among human adenoviruses: genome sequence and annotation of human adenovirus serotype 1

• DOI: 10.1099/vir.0.80118-0
• Publication Date: 2004-08-09T15:02:31Z
• Authors: Kim P. Lauer; Isabel Llorente; Eric Blair; Jason Seto; Vladimir Krasnov; Anjan Purkayastha; Susan E. Ditty; Ted L. Hadfield; Charles Buck; Clark Tibbetts; Donald Seto
• Keywords: 0303 health sciences; Adenoviruses, Human; Molecular Sequence Data; Genetic Variation; Genome, Viral; Polymerase Chain Reaction; 3. Good health; Adenovirus Infections, Human; 03 medical and health sciences; Military Personnel; Species Specificity; Humans; Capsid Proteins; Amino Acid Sequence; Serotyping; Sequence Alignment; DNA Primers

The 36 001 base pair DNA sequence of human adenovirus serotype 1 (HAdV-1) has been determined, using a ‘leveraged primer sequencing strategy’ to generate high quality sequences economically. This annotated genome (GenBank AF534906) confirms anticipated similarity to closely related species C (formerly subgroup), human adenoviruses HAdV-2 and -5, and near identity with earlier reports of sequences representing parts of the HAdV-1 genome. A first round of HAdV-1 sequence data acquisition used PCR amplification and sequencing primers from sequences common to the genomes of HAdV-2 and -5. The subsequent rounds of sequencing used primers derived from the newly generated data. Corroborative re-sequencing with primers selected from this HAdV-1 dataset generated sparsely tiled arrays of high quality sequencing ladders spanning both complementary strands of the HAdV-1 genome. These strategies allow for rapid and accurate low-pass sequencing of genomes. Such rapid genome determinations facilitate the development of specific probes for differentiation of family, serotype, subtype and strain (e.g. pathogen genome signatures). These will be used to monitor epidemic outbreaks of acute respiratory disease in a defined test bed by the Epidemic Outbreak Surveillance (EOS) project.